|
Volumn 52, Issue 9, 2004, Pages 521-529
|
Analysis of patients with hypoglycemia and/or hyperglycemia induced by gatifloxacin. Risk factors and patient profiles
a b c |
Author keywords
Diabetic; Gatifloxacin; Hyperglycemia; Hypoglycemia; Renal dysfunction
|
Indexed keywords
ACARBOSE;
ANTIARRHYTHMIC AGENT;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
CIBENZOLINE SUCCINATE;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DISOPYRAMIDE PHOSPHATE;
ENOXACIN;
GATIFLOXACIN;
GLIBENCLAMIDE;
GLICLAZIDE;
INDOMETACIN;
INSULIN;
LEVOFLOXACIN;
LOMEFLOXACIN;
METFORMIN;
MITOTANE;
NATEGLINIDE;
OFLOXACIN;
PIOGLITAZONE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
SULFONYLUREA;
VOGLIBOSE;
ADULT;
AGE;
AGED;
ARTICLE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG CONTRAINDICATION;
DRUG LABELING;
FEMALE;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
JAPAN;
KIDNEY DYSFUNCTION;
MAJOR CLINICAL STUDY;
MALE;
RISK FACTOR;
TABLET;
|
EID: 6944226256
PISSN: 13407007
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (23)
|